East Ventures launched a white paper on genomics in collaboration with the Ministry of Health of the Republic of Indonesia
East Ventures today launched a white paper “Genomics: Leapfrogging into the Indonesian healthcare future” in collaboration with the Ministry of Health of the Republic of Indonesia and Redseer Strategy Consultants, to provide a comprehensive understanding of how genomics can improve the healthcare system in Indonesia. This white paper serves as a guide for stakeholders in taking the necessary steps to improve our healthcare system and infrastructure for the future.
Why Indonesia should embrace genomics now
Two of the most critical pain points of Indonesia's healthcare system is the high mortality rates for non-communicable diseases, and high cost of treatment. The solution to this is developing genomics. Genomics technology will allow for early detection and targeted treatment, paving the way ahead to transform our healthcare system.
A healthy lifestyle begins at your fingertips
A study from the AIA Group in 2018 showed that Indonesia ranked the lowest in the Asia Pacific regarding the application of a healthy lifestyle. Despite being satisfied with their health condition, the research also revealed that Indonesians’ healthy living activities decreased from 4.0 in 2016 to 3.6 in 2018.
Indonesia’s Health & Biotechnology Investment Opportunities
During the East Ventures Summit 2022, Budi Gunadi Sadikin, Indonesian Minister of Health, was invited to become our keynote speaker, who presented his few insights on Indonesia's Health & Biotechnology Investment Opportunities.
East Ventures supports Indonesia’s Ministry of Health in launching the Biomedical & Genome Science Initiative (BGSi)
East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 250 companies in Southeast Asia, supports the launch of the Biomedical & Genome Science Initiative (BGSi), an initiative of Indonesia’s Ministry of Health (Kemenkes) to provide precision medicine services for the community. This inauguration occurred on Sunday, 14 August 2022, at the Eijkman Building, Dr. RSUPN. Cipto Mangunkusumo (RSCM).
Diri Care, a consumer health technology startup, closes US$4.3 million in seed funding co-led by East Ventures and Sequoia Capital India & Southeast Asia’s Surge
Diri Care, a consumer health technology startup, has closed its oversubscribed seed round at US$ 4.3 million, co-led by East Ventures and Sequoia Capital India and Southeast Asia’s Surge, with follow-on participation from prominent angel investor, Henry Hendrawan.
Rising biotech innovations to address Indonesia’s healthcare problems
With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop a more resilient healthcare system and innovations.
The promising rise of mental health startups in Indonesia
The urgency for innovation and access in the mental health vertical has never been more pivotal. On a macro level, there has been a global shift in consumer demand for quality health and wellness services and a significant lift in education and affluence in Southeast Asia, presenting a promising context for this industry.